China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
CN |
|
Plato Gold Corp
F:4Y7
|
CA |
|
AI/ML Innovations Inc
OTC:AIMLF
|
CA |
|
Genasys Inc
NASDAQ:GNSS
|
US |
|
M2i SA
PAR:ALMII
|
FR |
|
7
|
7-Eleven Malaysia Holdings Bhd
KLSE:SEM
|
MY |
|
China Health Industries Holdings Inc
OTC:CHHE
|
CN |
|
A
|
Aurora Design PCL
SET:AURA
|
TH |
|
Barry Callebaut AG
OTC:BRRLY
|
CH |
|
Spartan Resources Ltd
ASX:SPR
|
AU |
|
Millennium Services Group Ltd
ASX:MIL
|
AU |
|
Caseys General Stores Inc
NASDAQ:CASY
|
US |
|
B
|
BlueVenture Group PCL
SET:BVG
|
TH |
|
R
|
Resource Base Ltd
ASX:RBX
|
AU |
|
L
|
Lithium Royalty Corp
TSX:LIRC
|
CA |
|
S
|
Sunrun Inc
F:3S9
|
US |
|
Plastiques du Val de Loire SA
PAR:PVL
|
FR |
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
|
AU |
|
Adobe Inc
NASDAQ:ADBE
|
US |
Wall St Price Targets
Price Targets Summary
China National Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 37.16 CNY with a low forecast of 35.21 CNY and a high forecast of 39.9 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is China National Medicines Corp Ltd's stock price target?
Price Target
37.16
CNY
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 37.16 CNY with a low forecast of 35.21 CNY and a high forecast of 39.9 CNY.
What is the Revenue forecast for China National Medicines Corp Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for China National Medicines Corp Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is 12%.
What is the Operating Income forecast for China National Medicines Corp Ltd?
Projected CAGR
81%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 1 year is 81%.
What is the Pre-Tax Income forecast for China National Medicines Corp Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for China National Medicines Corp Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 3%.
